Company intelligence / Profile preview

ARCHIMEDlife

Ownership: Private
Development stage: Commercial

Overview

ARCHIMEDlife provides certified diagnostic laboratory services with a focus on rare disease biomarker discovery/validation. They offer commercialized tests using advanced mass spectrometry and NGS platforms. The company partners with pharma/biotech to support orphan drug development through high-quality biochemical testing. Over 20,000 physicians in more than 75 countries have used their services since launch. No therapeutic clinical trial results as they are not a therapeutics developer.

Therapeutic areas: OncologyCardiovascularRare DiseasesNeurology
Modalities: Diagnostic assay (Small molecule and protein profiling)Biomarker discovery and testingMass spectrometry-based diagnosticsNext-generation sequencing (NGS) diagnosticsIn-vitro diagnostic assays (IVD)
Industry: Molecular Diagnostics

Partnerships

Blueprint Genetics Oy – partnership to launch high quality biochemical testing for rare diseases in North America

Beyond the preview

Go deeper on ARCHIMEDlife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARCHIMEDlife.

Explore the full profile